Literature DB >> 9100357

High-density hybridoma perfusion culture. Limitation vs inhibition.

G G Banik1, C A Heath.   

Abstract

Because our earlier work indicated a strong correlation between specific antibody productivity and cell density in perfusion culture, we conducted experiments to determine the optimum means of increasing cell density while maintaining high antibody productivity. The rates of medium supply and waste removal were varied to determine whether cell density was limited or inhibited, and whether a diffusable substance could be responsible for the correlation between antibody productivity and cell density. Nutrient supply was found to be a stronger determinant of cell density than waste removal; however, the rate of waste removal had a greater effect on cell growth at lower cell densities. Even at noninhibitory levels of ammonia and lactate, cellular metabolism was regulated to minimize their concentrations at lowered rates of waste removal. Separate step changes in glucose and glutamine resulted in increased cell density and antibody concentration. Specific antibody productivity increased following the step in glutamine, but not glucose. Both steps caused changes in cellular metabolism that prevented the levels of lactate and ammonia from reaching toxic levels.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9100357     DOI: 10.1007/bf02787797

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  4 in total

1.  Optimization of the medium perfusion rate in a packed-bed bioreactor charged with CHO cells.

Authors:  F Meuwly; U von Stockar; A Kadouri
Journal:  Cytotechnology       Date:  2005-06-16       Impact factor: 2.058

2.  Comparison of cell growth in T-flasks, in micro hollow fiber bioreactors, and in an industrial scale hollow fiber bioreactor system.

Authors:  M J Gramer; D M Poeschl
Journal:  Cytotechnology       Date:  2000-10       Impact factor: 2.058

3.  The role of vitamins and amino acids on hybridoma growth and monoclonal antibody production.

Authors:  P Ducommun; P A Ruffieux; U von Stockar; I Marison
Journal:  Cytotechnology       Date:  2001-10       Impact factor: 2.058

4.  Bioprocess development for the production of mouse-human chimeric anti-epidermal growth factor receptor vIII antibody C12 by suspension culture of recombinant Chinese hamster ovary cells.

Authors:  Suwen Hu; Lei Deng; Huamao Wang; Yingping Zhuang; Ju Chu; Siliang Zhang; Zhonghai Li; Meijin Guo
Journal:  Cytotechnology       Date:  2011-02-05       Impact factor: 2.058

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.